What changed · Updated May 25
What changed this week.
We re-score every program in the chart every Monday morning. This page is the running log: which programs moved up, which moved down, what triggered the change.
Earlier updates
- 2026-05-27. PA letter library expanded from 60 to 200 templates. Added 10 plans (Independence Blue Cross, Highmark, CareFirst, Premera, Florida Blue, Horizon BCBS, Wellcare, Molina, Ambetter, Oscar Health) and 4 conditions (obesity Class III, T2D + CKD, MASH/NAFLD, prediabetes progression). Appeal letter library scaled to 120.
- 2026-05-23. Added 6 stacked-comorbidity composite pages (T2D+CKD+ASCVD, MASH+T2D+CKD, HFpEF+CKD, post-bariatric+T2D, transplant+obesity, T1D+post-bariatric). Spanish mirror of the condition library at /es/condicion/. MCO-level Medicaid coverage for the 15 highest-population states.
- 2026-05-23. Added evidence by condition: 8 trial-anchored profiles for T2D+CKD (FLOW), HFpEF (STEP-HFpEF, SUMMIT), MASH (ESSENCE), OSA (SURMOUNT-OSA), T2D+ASCVD (SELECT), PCOS, post-bariatric (BARI-OPTIMISE) and breastfeeding.
- 2026-05-23. PA letter combo pages now show a “what your PBM actually requires” panel for Caremark, Express Scripts, OptumRx, MedImpact and Magellan members.
- 2026-05-23. Added the appeal letter library (60 denial-rebuttal templates) and the PBM routing layer covering Caremark, Express Scripts, OptumRx, MedImpact and Magellan.
- 2026-05-23. Added the PA letter library: 60 plan-and-condition letter templates for the 10 largest US health plans.
- 2026-05-12. Chart expanded to 25 programs. Mochi leads on flat-pricing transparency.
- 2026-05-04. Calibrate program fee cut from $299/mo to $199/mo.
- 2026-05-02. Hims compounded semaglutide closed to new patients. Existing patients grandfathered.
Why you can trust GLP ChartSame scoring framework applied to every program. No paid placements. No removal of unfavorable information at advertiser request. Pricing is pulled from each program's public-facing page weekly.